{ "description": null, "compose": { "include": [ { "system": "http://www.ama-assn.org/go/cpt", "concept": [ { "code": "87340", "display": "Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen (HBsAg)" }, { "code": "87341", "display": "Infectious agent antigen detection by enzyme immunoassay technique, qualitative or semiquantitative, multiple-step method; hepatitis B surface antigen (HBsAg) neutralization" }, { "code": "87516", "display": "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, amplified probe technique" }, { "code": "87517", "display": "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification" }, { "code": "87912", "display": "Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus" } ] } ] }, "_filename": "del/ValueSet-2.16.840.1.113762.1.4.1116.32.json", "package_name": "us.nlm.vsac", "date": "2015-05-28T01:00:03-04:00", "meta": { "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ], "versionId": "4", "lastUpdated": "2023-04-03T14:03:54.000-04:00" }, "publisher": "CancerLinQ Steward", "jurisdiction": [ { "coding": [ { "code": "US", "system": "urn:iso:std:iso:3166" } ] } ], "purpose": "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )", "name": "HepatitisBAntigenTest", "type": null, "experimental": "false", "resourceType": "ValueSet", "expansion": { "total": 5, "contains": [ { "code": "87340", "system": "http://www.ama-assn.org/go/cpt", "display": "Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; hepatitis B surface antigen (HBsAg)", "version": "2024" }, { "code": "87341", "system": "http://www.ama-assn.org/go/cpt", "display": "Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; hepatitis B surface antigen (HBsAg) neutralization", "version": "2024" }, { "code": "87516", "system": "http://www.ama-assn.org/go/cpt", "display": "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, amplified probe technique", "version": "2024" }, { "code": "87517", "system": "http://www.ama-assn.org/go/cpt", "display": "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification", "version": "2024" }, { "code": "87912", "system": "http://www.ama-assn.org/go/cpt", "display": "Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus", "version": "2024" } ], "timestamp": "2023-11-26T16:28:30-05:00", "identifier": "urn:uuid:b438b07b-e7e6-4130-8dc7-39c918610c58" }, "title": "Hepatitis B Antigen Test", "package_version": "0.18.0", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueString": "CancerLinQ Author" }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2022-12-15" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2023-04-03" } ], "status": "active", "id": "b21a76b9-c80f-4280-bb8f-67cb12813df9", "kind": null, "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.32", "identifier": [ { "value": "urn:oid:2.16.840.1.113762.1.4.1116.32", "system": "urn:ietf:rfc:3986" } ], "version": "20150528" }